Weiner M F, Edland S D, Luszczynska H
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas 75235-9070.
Am J Psychiatry. 1994 Jul;151(7):1006-9. doi: 10.1176/ajp.151.7.1006.
This study examined the prevalence and incidence of major depressive disorder in Alzheimer's disease.
The authors retrospectively reviewed two large Alzheimer's disease databases, one at the University of Texas Southwestern Medical Center in Dallas and the other at the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). The Dallas series contained 264 cases of Alzheimer's disease, of which 153 patients were followed up for an average of 3 years from initial evaluation. The CERAD database contained 1,095 cases and excluded patients with histories of depression at initial evaluation; 325 of these patients were followed up for at least 2 years. Alzheimer's disease was diagnosed according to the criteria of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; major depression was diagnosed according to the DSM-III-R criteria. Most of the patients in these series were dwelling in the community and had had Alzheimer's disease symptoms for approximately 4 years at the time of evaluation.
In the Dallas series there was a 1.5% prevalence and a 0% incidence of major depression. In the CERAD series there was a 1.3% 2-year incidence of major depression.
The low prevalence and incidence of DSM-III-R major depression in these patients suggest that for the period of time the patients were followed up, Alzheimer's disease did not predispose to major depression. However, major depression may herald the subsequent onset of dementia. Depression in dementia should perhaps be diagnosed by different criteria.
本研究调查了阿尔茨海默病中重度抑郁症的患病率和发病率。
作者回顾性分析了两个大型阿尔茨海默病数据库,一个位于达拉斯的德克萨斯大学西南医学中心,另一个是阿尔茨海默病注册协会(CERAD)的数据库。达拉斯系列包含264例阿尔茨海默病患者,其中153例患者从初次评估开始平均随访3年。CERAD数据库包含1095例病例,并排除了初次评估时有抑郁症病史的患者;其中325例患者至少随访了2年。阿尔茨海默病根据美国国立神经疾病和中风研究所及阿尔茨海默病及相关疾病协会的标准进行诊断;重度抑郁症根据DSM-III-R标准进行诊断。这些系列中的大多数患者居住在社区,在评估时已有阿尔茨海默病症状约4年。
在达拉斯系列中,重度抑郁症的患病率为1.5%,发病率为0%。在CERAD系列中,重度抑郁症的2年发病率为1.3%。
这些患者中DSM-III-R重度抑郁症的低患病率和发病率表明,在患者随访期间,阿尔茨海默病不会引发重度抑郁症。然而,重度抑郁症可能预示着随后痴呆症的发作。痴呆症中的抑郁症或许应以不同标准进行诊断。